Abvc Biopharma (ABVC) Asset Utilization Ratio (2011 - 2025)
Abvc Biopharma's (ABVC) quarterly Asset Utilization Ratio came in at 0.01 in Q4 2025, down 118.19% YoY from 0.07 in Q4 2024, and down 118.19% on a QoQ basis from 0.07 in Q4 2024.
Abvc Biopharma (ABVC) Asset Utilization Ratio (2011 - 2025) Analysis & Trends
Abvc Biopharma (ABVC) has 12 years of Asset Utilization Ratio data on file, last reported at 0.01 in Q4 2025.
- Quarterly Asset Utilization Ratio fell 118.19% year-over-year to 0.01 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.01 (down 118.19% YoY) and the FY2025 annual result came in at 0.0, down 96.89% from the prior year.
- Asset Utilization Ratio fell to 0.01 in Q4 2025, from 0.07 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.11 in Q1 2023 to a low of 0.02 in Q1 2022.
- A 5-year average of 0.04 and a median of 0.04 in 2021 frame the typical range for Asset Utilization Ratio.
- The widest YoY moves for Asset Utilization Ratio: up 272381635.33% in 2022, down 130.57% in 2022.
- Tracing ABVC's Asset Utilization Ratio over 5 years: stood at 0.0 in 2021, then surged by 272381635.33% to 0.1 in 2022, then tumbled by 86.47% to 0.01 in 2023, then jumped by 408.52% to 0.07 in 2024, then tumbled by 118.19% to 0.01 in 2025.
- The last three Asset Utilization Ratio figures came in at 0.01 (Q4 2025), 0.07 (Q4 2024), and 0.06 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.50 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 86.12 Bn | 78.12 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.98 Bn | 53.84 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 42.08 Bn | 36.99 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 27.98 Bn | 9.59 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - | 0.13 |
| 10 | Abvc Biopharma | 22.67 Mn | 22.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.01 |
| Dec 31, 2024 | 0.07 |
| Sep 30, 2024 | 0.06 |
| Jun 30, 2024 | 0.02 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.01 |
| Sep 30, 2023 | 0.06 |
| Jun 30, 2023 | 0.08 |
| Mar 31, 2023 | 0.11 |
| Dec 31, 2022 | 0.10 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | -0.02 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.04 |
| Jun 30, 2021 | 0.05 |
| Mar 31, 2021 | 0.06 |
| Dec 31, 2020 | 0.05 |
| Sep 30, 2020 | 0.08 |
| Dec 31, 2019 | 0.10 |